|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Edwards BK, Ward E, Kohler BA, et al:
Annual report to the nation on the status of cancer, 1975–2006,
featuring colorectal cancer trends and impact of interventions
(risk factors, screening, and treatment) to reduce future rates.
Cancer. 116:544–573. 2010. View Article : Google Scholar
|
|
3
|
Kirkali Z, Chan T, Manoharan M, et al:
Bladder cancer: epidemiology, staging and grading, and diagnosis.
Urology. 66(Suppl 1): 4–34. 2005. View Article : Google Scholar
|
|
4
|
Wu D, Tao J, Ding J, et al:
Interleukin-11, an interleukin-6-like cytokine, is a promising
predictor for bladder cancer prognosis. Mol Med Rep. 7:684–688.
2013.
|
|
5
|
Hirata H, Ueno K, Shahryari V, et al:
Oncogenic miRNA-182–5p targets Smad4 and RECK in human bladder
cancer. PloS One. 7:e510562012. View Article : Google Scholar
|
|
6
|
Pasin E, Josephson DY, Mitra AP, et al:
Superficial bladder cancer: an update on etiology, molecular
development, classification, and natural history. Rev Urol.
10:31–43. 2008.PubMed/NCBI
|
|
7
|
Sylvester RJ, Oosterlinck W and van der
Meijden AP: A single immediate postoperative instillation of
chemotherapy decreases the risk of recurrence in patients with
stage Ta T1 bladder cancer: a meta-analysis of published results of
randomized clinical trials. J Urol. 171:2186–2190. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Said N, Sanchez-Carbayo M, Smith SC and
Theodorescu D: RhoGDI2 suppresses lung metastasis in mice by
reducing tumor versican expression and macrophage infiltration. J
Clin Invest. 122:1503–1518. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zang X, Sullivan PS, Soslow RA, Waitz R,
Reuter VE, Wilton A, Thaler HT, Arul M, Slovin SF, Wei J, et al:
Tumor associated endothelial expression of B7-H3 predicts survival
in ovarian carcinomas. Mod Pathol. 23:1104–1112. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hofmeyer KA, Ray A and Zang X: The
contrasting role of B7-H3. Proc Nat Acad Sci USA. 105:10277–10278.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zang X, Loke P, Kim J, Murphy K, Waitz R
and Allison JP: B7x: a widely expressed B7 family member that
inhibits T cell activation. Proc Nat Acad Sci USA. 100:10388–10392.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zang X and Allison JP: The B7 family and
cancer therapy: costimulation and coinhibition. Clin Cancer Res.
13:5271–5279. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Okazaki T and Honjo T: The PD-1-PD-L
pathway in immunological tolerance. Trends Immunol. 27:195–201.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Barber DL, Wherry EJ, Masopust D, Zhu B,
Allison JP, Sharpe AH, Freeman GJ and Ahmed R: Restoring function
in exhausted CD8 T cells during chronic viral infection. Nature.
439:682–687. 2006. View Article : Google Scholar
|
|
15
|
Zang X, Thompson RH, Al-Ahmadie HA, Serio
AM, Reuter VE, Eastham JA, Scardino PT, Sharma P and Allison JP:
B7-H3 and B7× are highly expressed in human prostate cancer and
associated with disease spread and poor outcome. Proc Nat Acad Sci
USA. 104:19458–19463. 2007. View Article : Google Scholar
|
|
16
|
Crispen PL, Sheinin Y, Roth TJ, Lohse CM,
Kuntz SM, Frigola X, Thompson RH, Boorjian SA, Dong H, Leibovich
BC, et al: Tumor cell and tumor vasculature expression of B7-H3
predict survival in clear cell renal cell carcinoma. Clin Cancer
Res. 14:5150–5157. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sun M, Richards S, Prasad DV, Mai XM,
Rudensky A and Dong C: Characterization of mouse and human B7-H3
genes. J Immunol. 168:6294–6297. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ling V, Wu PW, Spaulding V, Kieleczawa J,
Luxenberg D, Carreno BM and Collins M: Duplication of primate and
rodent B7-H3 immunoglobulin V- and C-like domains: divergent
history of functional redundancy and exon loss. Genomics.
82:365–377. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Waschbisch A, Wintterle S, Lochmuller H,
Walter MC, Wischhusen J, Kieseier BC and Wiendl H: Human muscle
cells express the costimulatory molecule B7-H3, which modulates
muscle-immune interactions. Arthritis Rheum. 58:3600–3608. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chapoval AI, Ni J, Lau JS, Wilcox RA,
Flies DB, Liu D, Dong H, Sica GL, Zhu G, Tamada K and Chen L:
B7-H3: a costimulatory molecule for T cell activation and IFN-gamma
production. Nat Immunol. 2:269–274. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sun Y, Wang Y, Zhao J, Gu M, Giscombe R,
Lefvert AK and Wang X: B7-H3 and B7-H4 expression in non-small-cell
lung cancer. Lung cancer. 53:143–151. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Arigami T, Uenosono Y, Hirata M, Yanagita
S, Ishigami S and Natsugoe S: B7-H3 expression in gastric cancer: a
novel molecular blood marker for detecting circulating tumor cells.
Cancer Sci. 102:1019–1024. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fauci JM, Straughn JM Jr, Ferrone S and
Buchsbaum DJ: A review of B7-H3 and B7-H4 immune molecules and
their role in ovarian cancer. Gynecol Oncol. 127:420–425. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Roth TJ, Sheinin Y, Lohse CM, Kuntz SM,
Frigola X, Inman BA, Krambeck AE, McKenney ME, Karnes RJ, Blute ML,
et al: B7-H3 ligand expression by prostate cancer: a novel marker
of prognosis and potential target for therapy. Cancer Res.
67:7893–7900. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Luo L, Chapoval AI, Flies DB, Zhu G,
Hirano F, Wang S, Lau JS, Dong H, Tamada K, Flies AS, et al: B7-H3
enhances tumor immunity in vivo by costimulating rapid clonal
expansion of antigen-specific CD8+ cytolytic T cells. J
Immunol. 173:5445–5450. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang L, Fraser CC, Kikly K, Wells AD, Han
R, Coyle AJ, Chen L and Hancock WW: B7-H3 promotes acute and
chronic allograft rejection. Eur J Immunol. 35:428–438. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Luo L, Qiao H, Meng F, Dong X, Zhou B,
Jiang H, Kanwar JR, Krissansen GW and Sun X: Arsenic trioxide
synergizes with B7H3-mediated immunotherapy to eradicate
hepatocellular carcinomas. Int J Cancer. 118:1823–1830. 2006.
View Article : Google Scholar
|
|
28
|
Lupu CM, Eisenbach C, Kuefner MA, Schmidt
J, Lupu AD, Stremmel W and Encke J: An orthotopic colon cancer
model for studying the B7-H3 antitumor effect in vivo. J
Gastrointest Surg. 10:635–645. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Suh WK, Gajewska BU, Okada H, Gronski MA,
Bertram EM, Dawicki W, Duncan GS, Bukczynski J, Plyte S, Elia A, et
al: The B7 family member B7-H3 preferentially down-regulates T
helper type 1-mediated immune responses. Nat Immunol. 4:899–906.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Prasad DV, Nguyen T, Li Z, Yang Y, Duong
J, Wang Y and Dong C: Murine B7-H3 is a negative regulator of T
cells. J Immunol. 173:2500–2506. 2004. View Article : Google Scholar : PubMed/NCBI
|
